Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
stocklegend's Profile
Displaying 1101-1150 of 1641 result(s).
PMCB PharmaCyte Biotech Inc.
02/13/2014 11:18:47 AM
$NVLX - Nuvilex Acquires Cancer Cel
PMCB PharmaCyte Biotech Inc.
02/13/2014 9:58:15 AM
$NVLX - Nuvilex Acquires Cancer Tec
PMCB PharmaCyte Biotech Inc.
02/13/2014 9:51:41 AM
$NVLX - Nuvilex Restructures to Foc
PMCB PharmaCyte Biotech Inc.
02/13/2014 9:04:45 AM
$NVLX - Nuvilex Contracts with Inno
PMCB PharmaCyte Biotech Inc.
02/13/2014 8:49:51 AM
$NVLX - Nuvilex Enters Most Importa
PMCB PharmaCyte Biotech Inc.
02/12/2014 2:16:34 PM
$NVLX – Nuvilex COO Talks About C
PMCB PharmaCyte Biotech Inc.
02/12/2014 1:50:35 PM
$NVLX – Nuvilex COO, Dr. Gerald C
PMCB PharmaCyte Biotech Inc.
02/12/2014 1:17:20 PM
$NVLX – Inno Biologics Begins Ce
PMCB PharmaCyte Biotech Inc.
02/12/2014 12:37:21 PM
$NVLX – Nuvilex Announces Clonin
PMCB PharmaCyte Biotech Inc.
02/12/2014 12:23:38 PM
$NVLX – Diabetes Treatment Drive
PMCB PharmaCyte Biotech Inc.
02/12/2014 11:16:30 AM
$NVLX – After Pancreatic Cancer,
PMCB PharmaCyte Biotech Inc.
02/12/2014 10:34:39 AM
$NVLX – Nuvilex Appoints Dr. Mark
PMCB PharmaCyte Biotech Inc.
02/12/2014 10:04:38 AM
$NVLX – Nuvilex Begins Making Mov
PMCB PharmaCyte Biotech Inc.
02/12/2014 9:41:47 AM
NVLX news: 
PMCB PharmaCyte Biotech Inc.
02/12/2014 8:59:23 AM
$NVLX – Nuvilex's Medical Marijua
PMCB PharmaCyte Biotech Inc.
02/11/2014 3:02:38 PM
$NVLX – Inno Biologics Begins Ce
PMCB PharmaCyte Biotech Inc.
02/11/2014 2:12:45 PM
$NVLX – Nuvilex COO, Dr. Gerald C
PMCB PharmaCyte Biotech Inc.
02/11/2014 2:07:56 PM
$NVLX – Nuvilex COO Talks About C
PMCB PharmaCyte Biotech Inc.
02/11/2014 1:34:03 PM
$NVLX – Nuvilex, Inc. Featured o
PMCB PharmaCyte Biotech Inc.
02/11/2014 12:59:23 PM
$NVLX – Nuvilex Listed in Forbes
PMCB PharmaCyte Biotech Inc.
02/11/2014 11:37:40 AM
$NVLX - Nuvilex COO Talks Medical M
PMCB PharmaCyte Biotech Inc.
02/11/2014 10:52:45 AM
$NVLX - Nuvilex Featured in Forbes
PMCB PharmaCyte Biotech Inc.
02/11/2014 10:24:06 AM
$NVLX - Nuvilex Acquires Cancer Cel
PMCB PharmaCyte Biotech Inc.
02/11/2014 10:05:32 AM
$NVLX - Nuvilex Acquires Cancer Tec
PMCB PharmaCyte Biotech Inc.
02/11/2014 9:43:35 AM
$NVLX - Nuvilex Restructures its Op
PMCB PharmaCyte Biotech Inc.
02/11/2014 9:25:17 AM
$NVLX - Nuvilex Restructures to Foc
PMCB PharmaCyte Biotech Inc.
02/11/2014 9:14:19 AM
$NVLX - Nuvilex Contracts with Inno
PMCB PharmaCyte Biotech Inc.
02/11/2014 9:00:22 AM
$NVLX - Nuvilex Enters Most Import
PMCB PharmaCyte Biotech Inc.
02/10/2014 3:54:04 PM
$NVLX – Nuvilex Announces Cloning
PMCB PharmaCyte Biotech Inc.
02/10/2014 3:16:57 PM
$NVLX – Nuvilex Completes Acquisi
PMCB PharmaCyte Biotech Inc.
02/10/2014 2:27:48 PM
$NVLX – Nuvilex Accelerates Devel
PMCB PharmaCyte Biotech Inc.
02/10/2014 2:07:13 PM
$NVLX – Nuvilex's Acquisition of
PMCB PharmaCyte Biotech Inc.
02/10/2014 1:18:05 PM
$NVLX – Nuvilex Ahead of the Curv
PMCB PharmaCyte Biotech Inc.
02/10/2014 12:32:35 PM
$NVLX – Diabetes Treatment Drive
PMCB PharmaCyte Biotech Inc.
02/10/2014 11:49:53 AM
$NVLX – After Pancreatic Cancer,
PMCB PharmaCyte Biotech Inc.
02/10/2014 11:08:37 AM
$NVLX – Nuvilex and Eli Lilly Go
PMCB PharmaCyte Biotech Inc.
02/10/2014 10:13:18 AM
$NVLX – Nuvilex Appoints Dr. Mark
PMCB PharmaCyte Biotech Inc.
02/10/2014 9:36:34 AM
$NVLX – Nuvilex Begins Making Mo
PMCB PharmaCyte Biotech Inc.
02/10/2014 9:11:19 AM
NVLX news: 
PMCB PharmaCyte Biotech Inc.
02/10/2014 8:44:37 AM
$NVLX – Nuvilex's Medical Marijua
PMCB PharmaCyte Biotech Inc.
02/07/2014 3:37:01 PM
$NVLX – Nuvilex Announces Cloning
PMCB PharmaCyte Biotech Inc.
02/07/2014 3:25:29 PM
$NVLX – Inno Biologics Begins Cel
PMCB PharmaCyte Biotech Inc.
02/07/2014 2:48:43 PM
$NVLX – Nuvilex COO, Dr. Gerald C
PMCB PharmaCyte Biotech Inc.
02/07/2014 2:01:51 PM
$NVLX – Nuvilex COO Talks About C
PMCB PharmaCyte Biotech Inc.
02/07/2014 1:32:49 PM
$NVLX – Nuvilex, Inc. Featured on
PMCB PharmaCyte Biotech Inc.
02/07/2014 12:36:18 PM
$NVLX – Nuvilex Listed in Forbes
PMCB PharmaCyte Biotech Inc.
02/07/2014 11:55:36 AM
$NVLX - Nuvilex COO Talks Medical M
PMCB PharmaCyte Biotech Inc.
02/07/2014 11:38:51 AM
$NVLX - Nuvilex Featured in Forbes
PMCB PharmaCyte Biotech Inc.
02/07/2014 10:59:14 AM
$NVLX - Nuvilex Acquires Cancer Cel
PMCB PharmaCyte Biotech Inc.
02/07/2014 10:11:32 AM
$NVLX - Nuvilex Acquires Cancer Tec
Go to page:
  • << First
  • < Previous
  • 22
  • 23
  • Next >

Recent Articles

  • Cytokinetics Opens Applications for Annual Communications Grant
  • LEQEMBI: New Hope for Alzheimer's Patients in Australia
  • MAX Power Secures $5 Million Investment to Explore Natural Hydrogen Opportunities
  • Kura Oncology to Showcase Innovations at Virtual Conference
  • Updates on ROCKWOOL A/S Share Buy-Back Efforts for Investors
  • Innovative Solar Solutions Enhance Electric Reefer Trailers Efficiency
  • Southern Michigan Bancorp’s Quarterly Cash Dividend Announcement
  • Cryptocurrency Trends: Stability and Insights for Investors
  • Meta's Delay in Providing AI Chatbot Records Sparks Concerns
  • Jiuzi Holdings Inc. Approves Bold Crypto Investment Strategy
  • SKF Restructures Industrial Division for Enhanced Growth
  • Cavendish Hydrogen Expands Collaboration with PAK-PCE H2
  • Cavendish Hydrogen Secures Major Upgrade Contract in Poland
  • ProRx Pharma Achieves DEA Registration for Controlled Substances
  • Southern Michigan Bancorp Announces New Cash Dividend Payment
  • Kura Oncology: Engaging Investors at Upcoming Conference
  • MAX Power Secures $5 Million Investment for Hydrogen Venture
  • Outcrop Silver Receives C$4.1 Million from Warrant Exercise
  • SKF Revamps Industrial Structure for Enhanced Performance
  • Phemex Launches Global Promotion for Cost-Effective Deposits
  • Cambridge Global Advisors Strengthens Team with Strategic Additions
  • b.well Introduces Innovative Digital Quality Measures Solution
  • Replicate Bioscience Advances Innovative Vaccine Technology
  • SKF Enhances Industrial Structure for Greater Global Impact
  • Tryg Forsikring A/S Succeeds with Tier 2 Capital Notes Offering
  • Recent Delistings Impacting Various Companies on Nasdaq
  • Lantheus Holdings Inc Faces Class Action Lawsuit for Losses
  • Emobi and Curo Join Forces to Enhance EV Charging Solutions
  • Braavo Capital Marks 10 Years of Empowering App Growth Journey
  • Sercomm Launches Advanced Testing Facility to Enhance Connectivity Solutions
  • Pathios Therapeutics Welcomes Dr. Jon Wigginton to Board
  • Jiuzi Holdings Announces Investment in Crypto Assets Strategy
  • Apollo Silver Corp. Partners with Capital Analytica for Growth
  • Sagimet Biosciences' Role in Advancing AI in Drug Development
  • Nevada Lithium Resources Partners with Hydro Lithium for Progress
  • Baker Hughes Schedules Q3 Earnings Call for Investors and Media
  • Prepare for BIO-Europe 2025: Networking for Biopharma Success
  • Cidara Therapeutics Advances Phase 3 Trial for CD388 Flu Prevention
  • Wrap Technologies Welcomes Joseph Cameron as Chief Revenue Officer
  • Oroco Appoints Faysal Rodriguez to Board for Strategic Growth
  • Global Crypto Trading Takes Center Stage with WSCT Launch
  • Sachem Capital Corp. Celebrates Redemption of Unsecured Notes
  • AGF Management Limited Announces Dividend for Stakeholders
  • Apollo Silver Partners with Capital Analytica for Growth
  • Insight Molecular Diagnostics to Highlight Kidney Transplant Advances
  • FibroGen Leads Innovative Treatment Trials in Prostate Cancer
  • Celebrating Cinema: The Silk Road International Film Festival
  • uniQure Secures Major Non-Dilutive Funding Boost for Growth
  • AGF Management Limited Announces Q3 2025 Dividend Strategy
  • AGF Management Reports Strong Q3 Results and Leadership Changes
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site